跳至主要内容
临床试验/JPRN-UMIN000028730
JPRN-UMIN000028730已完成未知

Effect of PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitor on long term outcomes in patients with acute myocardial infarction: multicenter randomized controlled trial - Effect of PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitor on long term outcomes in patients with acute myocardial infarction: multicenter randomized controlled trial

Kagawa Prefectural Central Hospital0 个研究点目标入组 180 人开始时间: 2017年9月4日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • cardiogenic shock, dialysis cases, cardiopulmonary arrest, severe liver disease, active malignancy, Unable to ingest statins, patients using PCSK9 inhibitors, patients with side effects on PCSK9 inhibitors in the past , Participating in another trial, a patient who is pregnant or has a possibility of pregnancy, a patient judged inappropriate by another doctor

研究者

相似试验